CapnoLine
Device
Covidien LP
Total Payments
$1.1M
Transactions
132
Doctors
24
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $124,465 | 56 | 14 |
| 2017 | $961,917 | 76 | 17 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $915,712 | 57 | 84.3% |
| Consulting Fee | $150,487 | 31 | 13.9% |
| Travel and Lodging | $7,342 | 10 | 0.7% |
| Space rental or facility fees (teaching hospital only) | $7,315 | 11 | 0.7% |
| Grant | $3,740 | 5 | 0.3% |
| Food and Beverage | $1,786 | 18 | 0.2% |
Payments by Type
Research
$915,712
57 transactions
General
$170,670
75 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prodigy | Covidien LP | $418,382 | 9 |
| Capnography at the bedside: Leading Education Efforts (CapAble Trial) | Covidien LP | $82,818 | 1 |
| Observational Investigation to Determine Impact of Continuous Surveillance Monitoring to provide early identification of acute respiratory compromise | Covidien LP | $63,134 | 0 |
| GCF | Covidien LP | $57,192 | 0 |
| Emergency Department Triage Use of End-Tidal Carbon Dioxide as the Sixth Vital Sign: An Effective Quality and Patient Safety Approach | Covidien LP | $47,300 | 0 |
| Sedation Outcomes During Intervention Procedures: Adverse Events and Near Misses | Covidien LP | $41,772 | 1 |
| Vandy IPI GCF | Covidien LP | $40,424 | 2 |
| Sedation Outcomes During lnterventional Procedures: Adverse Events and Near Misses | Covidien LP | $32,489 | 0 |
| A Pilot Observational Trial to Quantify the Potential Clinical Utility of Capnography in PACU | Covidien LP | $31,731 | 0 |
| A Pilot Observational Trial to Quanitify the Potential Clinical Utility of Capnography in PACU | Covidien LP | $24,788 | 0 |
| Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk | Covidien LP | $21,792 | 1 |
| Observational investigation to determine compliance and Clinical Impact of Continuous surveillance monitoring on general care floors with a nested observational study to determine the clinical utility | Covidien LP | $12,000 | 0 |
| Capnography-GFC | Covidien LP | $10,063 | 2 |
| Postoperative respiratory monitoring after neuraxial opioid administration for cesarean delivery | Covidien LP | $8,394 | 0 |
| Capnograpy at the bedside: Leading Education Efforts CapAble Trial | Covidien LP | $7,150 | 0 |
| investigation of respiratory depression among postpartum women undergoing cesarean delivery with neuraxial opioid administration | Covidien LP | $6,478 | 0 |
| Use of Integrated Pulmonary Index to Predict Post Operative Respiratory Adverse Events in High Risk Patients | Covidien LP | $3,090 | 0 |
| Preliminary characterization of the Capnography profile of obstructive sleep apnea OSA patients in the post-anesthesia care unit PACU | Covidien LP | $3,000 | 0 |
| A Pilot Observational Trial to Quantify the Potential Clinical Utility of Capnography in the PACU | Covidien LP | $2,488 | 0 |
| Preliminary Characterization of the Capnography Profile of Obstructive Sleep Apnea OSA Patients in the Post-Anesthesia Care Unit PACU | Covidien LP | $1,031 | 0 |
Top Doctors Receiving Payments for CapnoLine
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Oklahoma City, OK | $344,833 | 33 |
| , M.D | Critical Care Medicine | Cleveland, OH | $122,302 | 8 |
| , M.D | Anesthesiology | Boston, MA | $119,017 | 5 |
| , MD | Anesthesiology | Columbus, OH | $110,598 | 6 |
| , MD | Pediatric Emergency Medicine | New Haven, CT | $82,818 | 2 |
| , M.D | Anesthesiology | Rochester, MN | $71,468 | 14 |
| , M.D | Anesthesiology | Ann Arbor, MI | $55,187 | 15 |
| , MD | Anesthesiology | Fort Lauderdale, FL | $54,600 | 7 |
| , M.D | Anesthesiology | Royal Oak, MI | $26,039 | 4 |
| , MD | Anesthesiology | Charleston, SC | $25,683 | 9 |
| , MD | Anesthesiology | Stony Brook, NY | $21,792 | 1 |
| , MD | Pulmonary Disease | Cleveland, OH | $16,289 | 6 |
| , M.D | Anesthesiology | Nashville, TN | $12,962 | 2 |
| , MD | Surgery | Aurora, CO | $7,813 | 3 |
| , M.D | Critical Care Medicine | Nashville, TN | $6,013 | 2 |
| , M.D | Anesthesiology | Everett, WA | $4,135 | 3 |
| , M.D | Critical Care Medicine | Royal Oak, MI | $3,696 | 1 |
| Selwyn Lee | Anesthesiology | South Lake Tahoe, CA | $362.69 | 4 |
| , MD | Surgical Critical Care | Washington, DC | $127.59 | 1 |
| , MD | Critical Care Medicine | Chicago, IL | $127.59 | 1 |
| , MD | Anesthesiology | Evanston, IL | $127.59 | 1 |
| , MD | Internal Medicine | Cleveland, OH | $124.99 | 1 |
| , M.D | Anesthesiology | Cleveland, OH | $124.99 | 1 |
| , MD | Foot and Ankle Surgery | Columbus, OH | $124.99 | 1 |
| , MD | Internal Medicine | Ypsilanti, MI | $16.92 | 1 |
Ad
Manufacturing Companies
- Covidien LP $1.1M
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 24
- Transactions 132
About CapnoLine
CapnoLine is a device associated with $1.1M in payments to 24 healthcare providers, recorded across 132 transactions in the CMS Open Payments database. The primary manufacturer is Covidien LP.
Payment data is available from 2017 to 2018. In 2018, $124,465 was paid across 56 transactions to 14 doctors.
The most common payment nature for CapnoLine is "Unspecified" ($915,712, 84.3% of total).
CapnoLine is associated with 20 research studies, including "Prodigy" ($418,382).